Previous studies have established that curcumin can inhibit the activity of DNMT in non‐alcoholic fatty liver disease, reducing the PPARα promoter methylation and subsequent hepatocyte apoptosis (Li et al. 2018). This evidence concerns the gene PPARA and metabolic dysfunction-associated steatotic liver disease.